Top Markets
Coin of the day
Zhejiang Jingxin Pharmaceutical Co., Ltd. Zhejiang Jingxin Pharmaceutical Co., Ltd.

Zhejiang Jingxin Pharmaceutical Co., Ltd.

002020
Rangering i aksjer #7322
Zhejiang Jingxin Pharmaceutical Co., Ltd. is a Chinese enterprise engaged in... Zhejiang Jingxin Pharmaceutical Co., Ltd. is a Chinese enterprise engaged in the full spectrum of pharmaceutical activities, from research and development to manufacturing and sales within the country. Its diverse product line includes active pharmaceutical ingredients (APIs), along with a wide array of finished medications such as antihypertensives, various antibiotics (including quinolones and cephalosporins), gastrointestinal remedies, antidiabetics, antipileptics, antihistamines, H+ pump inhibitors, H2 receptor blockers, cholesterol-lowering drugs, and antidepressants, as well as biopharmaceutical products. Additionally, the company is a provider of advanced medical display solutions, offering diagnostic, surgical, clinical, large-screen, integrated, and ultrasonic medical displays. Originally founded in 1974 as Zhejiang Jingxin Pharmaceutical Factory, the company officially rebranded to Zhejiang Jingxin Pharmaceutical Co., Ltd. in 2000 and maintains its headquarters in Xinchang, China.
Aksjekurs
$1.89
Markedsverdi
$1.63B
Endring (1 dag)
-1.43%
Endring (1 år)
-26.46%
Land
CN
Handel Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020)

Kategori

Inntekter for Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Zhejiang Jingxin Pharmaceutical Co., Ltd. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Zhejiang Jingxin Pharmaceutical Co., Ltd. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter